4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001689575-25-000010
CHIEF EXECUTIVE OFFICER sold 12,858 shares at an average $108.17 ($1,390,911)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −606 | $105.10 | $63,690 | 13,972 | D |
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −1,092 | $106.69 | $116,506 | 12,880 | D |
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −4,462 | $107.61 | $480,160 | 8,418 | D |
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −5,163 | $108.55 | $560,457 | 3,255 | D |
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −554 | $109.13 | $60,458 | 2,701 | D |
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −200 | $110.23 | $22,046 | 2,501 | D |
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −645 | $111.84 | $72,134 | 1,856 | D |
| Stueland Katherine CHIEF EXECUTIVE OFFICER | 2025-09-30 | Sale 10b5-1 | −136 | $113.68 | $15,460 | 1,720 | D |
| Open-market sales · 12,858 sh · avg $108.17 · $1,390,911 | |||||||
Loading xslF345X05/form4-10012025_081057.xml…